{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:45:05Z","timestamp":1790905505169,"version":"4.1.0"},"reference-count":76,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007505","name":"Kirsten og Freddy Johansens Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007505","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>The lysosomal storage disorder Fabry disease is caused by deficient or absent activity of the <jats:italic>GLA<\/jats:italic> gene enzyme \u03b1-galactosidase A. In the present study we present the molecular and biochemical data of the Danish Fabry cohort and report 20 years\u2019 (2001\u20132020) experience in cascade genetic screening at the Danish National Fabry Disease Center. The Danish Fabry cohort consisted of 26 families, 18 index patients (9 males and 9 females, no available data for 8 index-patients) and 97 family members with a pathogenic <jats:italic>GLA<\/jats:italic> variant identified by cascade genetic testing (30 males and 67 females). Fourteen patients (5 males and 9 females; mean age of death 47.0 and 64.8 years respectively) died during follow-up. The completeness of the Fabry patient identification in the country has resulted in a cohort of balanced genotypes according to gender (twice number of females compared to males), indicating that the cohort was not biased by referral, and further resulted in earlier diagnosis of the disease by a lower age at diagnosis in family members compared to index-patients (mean age at diagnosis: index-patients 42.2 vs. family members 26.0 years). Six previously unreported disease-causing variants in the <jats:italic>GLA<\/jats:italic> gene were discovered. The nationwide screening and registration of Fabry disease families provide a unique possibility to establish a complete cohort of Fabry patients and to advance current knowledge of this inherited rare lysosomal storage disorder.<\/jats:p>","DOI":"10.1371\/journal.pone.0277767","type":"journal-article","created":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T18:28:11Z","timestamp":1668623291000},"page":"e0277767","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Systematic cascade screening in the Danish Fabry Disease Centre: 20 years of a national single-centre experience"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7313-8391","authenticated-orcid":true,"given":"Grigoris","family":"Effraimidis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c5se Krogh","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Dunoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lis F.","family":"Hasholt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flemming","family":"Wibrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5898-8048","authenticated-orcid":true,"given":"Soren S.","family":"Sorensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6091-7879","authenticated-orcid":true,"given":"Allan M.","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6635-1466","authenticated-orcid":true,"given":"Lars","family":"Kober","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Bundgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puriya D. W.","family":"Yazdanfard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9828-9185","authenticated-orcid":true,"given":"Peter","family":"Oturai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibeke A.","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8416-013X","authenticated-orcid":true,"given":"Vitor Hugo Fraga","family":"de Abreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7325-937X","authenticated-orcid":true,"given":"Lotte Hahn","family":"Enevoldsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Svenstrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margrethe Bastholm","family":"Bille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah","family":"Arif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6479-6034","authenticated-orcid":true,"given":"Mette","family":"Mogensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4230-4251","authenticated-orcid":true,"given":"Mads","family":"Klokker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibeke","family":"Backer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Kistorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5903-3355","authenticated-orcid":true,"given":"Ulla","family":"Feldt-Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,11,16]]},"reference":[{"issue":"21","key":"pone.0277767.ref001","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJM196705252762101","article-title":"Enzymatic Defect in Fabry\u2019s Disease","volume":"276","author":"RO Brady","year":"1967","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"pone.0277767.ref002","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.pharmthera.2009.01.003","article-title":"Fabry disease","volume":"122","author":"R. Schiffmann","year":"2009","journal-title":"Pharmacology & Therapeutics"},{"issue":"1","key":"pone.0277767.ref003","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF01986897","article-title":"Ein Beitrag zur Kenntniss der Purpura haemorrhagica nodularis (Purpura papulosa haemorrhagica Hebrae)","volume":"43","author":"J. Fabry","year":"1898","journal-title":"Archiv f\u00fcr Dermatologie und Syphilis"},{"issue":"4","key":"pone.0277767.ref004","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1365-2133.1898.tb16317.x","article-title":"A case of \u201cangeio-keratoma.\u201d","volume":"10","author":"W. Anderson","year":"1898","journal-title":"British Journal of Dermatology"},{"issue":"3","key":"pone.0277767.ref005","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.0954-6820.1947.tb06596.x","article-title":"Angiokeratoma corporis diffusum (universale) Fabry, as a sign of an unknown internal disease; two autopsy reports","volume":"128","author":"AWM Pompen","year":"2009","journal-title":"Acta Medica Scandinavica"},{"issue":"3922","key":"pone.0277767.ref006","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1126\/science.167.3922.1268","article-title":"Fabry\u2019s Disease: Alpha-Galactosidase Deficiency","volume":"167","author":"JA Kint","year":"1970","journal-title":"Science"},{"issue":"9","key":"pone.0277767.ref007","doi-asserted-by":"crossref","first-page":"PC3148","DOI":"10.1016\/S0021-9258(18)51888-3","article-title":"Fabry\u2019s Disease: Classification as a Sphingolipidosis and Partial Characterization of a Novel Glycolipid","volume":"238","author":"CC Sweeley","year":"1963","journal-title":"Journal of Biological Chemistry"},{"issue":"24","key":"pone.0277767.ref008","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1056\/NEJM197212142872411","article-title":"Enzyme Transplantation in Fabry\u2019s Disease","volume":"287","author":"W Krivit","year":"1972","journal-title":"New England Journal of Medicine"},{"issue":"13","key":"pone.0277767.ref009","doi-asserted-by":"crossref","first-page":"4859","DOI":"10.1073\/pnas.83.13.4859","article-title":"Human alpha-galactosidase A: nucleotide sequence of a cDNA clone encoding the mature enzyme","volume":"83","author":"DF Bishop","year":"1986","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"11","key":"pone.0277767.ref010","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1073\/pnas.85.11.3903","article-title":"Structural organization of the human alpha-galactosidase A gene: further evidence for the absence of a 3\u2019 untranslated region","volume":"85","author":"DF Bishop","year":"1988","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"4","key":"pone.0277767.ref011","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1172\/JCI114027","article-title":"Fabry disease: six gene rearrangements and an exonic point mutation in the alpha-galactosidase gene","volume":"83","author":"HS Bernstein","year":"1989","journal-title":"Journal of Clinical Investigation"},{"key":"pone.0277767.ref012","volume-title":"Angiokeratoma Corporis Diffusum (Fabry\u2019s Sygdom)","author":"Lou Christensen","year":"1972"},{"issue":"4","key":"pone.0277767.ref013","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1399-0004.1974.tb01708.x","article-title":"An example of rapid prenatal diagnosis of Fabry\u2019s disease using microtechniques","volume":"5","author":"H Galjaard","year":"2008","journal-title":"Clinical Genetics"},{"issue":"2","key":"pone.0277767.ref014","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/00365519609088605","article-title":"The utility of single-strand conformation polymorphism (SSCP) analysis: Results obtained in families with Fabry\u2019s disease","volume":"56","author":"KM Madsen","year":"1996","journal-title":"Scandinavian Journal of Clinical and Laboratory Investigation"},{"key":"pone.0277767.ref015","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1530\/eje.0.1460741","article-title":"Fabry disease: a new challenge in endocrinology and metabolism?","author":"U Feldt-Rasmussen","year":"2002","journal-title":"European Journal of Endocrinology"},{"issue":"5","key":"pone.0277767.ref016","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1377\/hlthaff.2017.1630","article-title":"Delivery Of Cascade Screening For Hereditary Conditions: A Scoping Review Of The Literature","volume":"37","author":"MC Roberts","year":"2018","journal-title":"Health Affairs"},{"key":"pone.0277767.ref017","unstructured":"National Cancer Institute. NCI Dictionaries. https:\/\/www.cancer.gov\/publications\/dictionaries\/genetics-dictionary\/def\/cascade-screening. Accessed November 20, 2021."},{"issue":"0","key":"pone.0277767.ref018","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/08035320600618759","article-title":"The pattern of inheritance of X-linked traits is not dominant or recessive, just X-linked","volume":"95","author":"W. Dobyns","year":"2006","journal-title":"Acta Paediatrica"},{"key":"pone.0277767.ref019","unstructured":"fabry-database. http:\/\/fabry-database.org Accessed November 16, 2021."},{"key":"pone.0277767.ref020","unstructured":"International Fabry Disease Genotype- Phenotype Database http:\/\/dbfgp.org\/dbFgb\/fabry\/ Accessed November 16, 2021."},{"key":"pone.0277767.ref021","unstructured":"Danmarks Statistik. Befolkningstal. https:\/\/www.dst.dk\/da\/Statistik\/emner\/befolkning-og-valg\/befolkning-og-befolkningsfremskrivning\/folketal. Accessed November 16, 2021."},{"key":"pone.0277767.ref022","unstructured":"Facts about Greenland\u2014Naalakkersuisut. https:\/\/naalakkersuisut.gl\/en\/About-government-of-greenland\/About-Greenland\/Facts-about-Greenland. Accessed November 16, 2021."},{"key":"pone.0277767.ref023","unstructured":"The official gateway to the Faroe Islands. Faroe Islands population https:\/\/www.faroeislands.fo\/people-society\/people-of-the-faroe-islands\/population\/ Accessed November 16, 2021."},{"key":"pone.0277767.ref024","unstructured":"Danish Council of Ethics Genome testing\u2014Ethical dilemmas in diagnosis, in research and direct-to-consumer https:\/\/www.etiskraad.dk\/~\/media\/Etisk-Raad\/en\/Publications\/Genome-testing-report-2012.pdf?la=da Accessed June 1, 2022."},{"issue":"3","key":"pone.0277767.ref025","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/humu.1380050316","article-title":"Two novel mutations (L32P) and (G85N) among five different missense mutations in six Danish families with Fabry\u2019s disease","volume":"5","author":"KM Madsen","year":"1995","journal-title":"Human Mutation"},{"issue":"3","key":"pone.0277767.ref026","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ymgme.2011.05.008","article-title":"Diagnostic dilemma: A young woman with Fabry disease symptoms, no family history, and a \u201csequencing cryptic\u201d \u03b1-galactosidase a large deletion","volume":"104","author":"U Feldt-Rasmussen","year":"2011","journal-title":"Molecular Genetics and Metabolism"},{"issue":"5","key":"pone.0277767.ref027","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/1479-7364-2-5-297","article-title":"Fabry disease: Identification of 50 novel \u03b1-galactosidase A mutations causing the classic phenotype and three-dimensional structural analysis of 29 missense mutations","volume":"2","author":"J Shabbeer","year":"2006","journal-title":"Human Genomics"},{"issue":"6","key":"pone.0277767.ref028","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/humu.21474","article-title":"Detection of large gene rearrangements in X-linked genes by dosage analysis: identification of novel \u03b1-galactosidase A (GLA) deletions causing Fabry disease","volume":"32","author":"R Dobrovolny","year":"2011","journal-title":"Human Mutation"},{"issue":"8","key":"pone.0277767.ref029","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00109-005-0656-2","article-title":"Relationship between X-inactivation and clinical involvement in Fabry heterozygotes. Eleven novel mutations in the \u03b1-galactosidase A gene in the Czech and Slovak population","volume":"83","author":"R Dobrovolny","year":"2005","journal-title":"Journal of Molecular Medicine"},{"issue":"2","key":"pone.0277767.ref030","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1016\/j.ymgme.2017.12.097","article-title":"The D313Y variant in the GLA gene\u2014no evidence of a pathogenic role in Fabry disease in 2 Danish families","volume":"123","author":"U Feldt-Rasmussen","year":"2018","journal-title":"Molecular Genetics and Metabolism"},{"issue":"2","key":"pone.0277767.ref031","first-page":"157","article-title":"Fabry\u2019s disease: enzymatic diagnosis of hemizygotes and heterozygotes. Alpha-galactosidase activities in plasma, serum, urine, and leukocytes","volume":"81","author":"RJ Desnick","year":"1973","journal-title":"J Lab Clin Med"},{"issue":"22","key":"pone.0277767.ref032","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1136\/heartjnl-2014-305616","article-title":"Familial globotriaosylceramide-associated cardiomyopathy mimicking Fabry disease","volume":"100","author":"T Apelland","year":"2014","journal-title":"Heart"},{"issue":"1","key":"pone.0277767.ref033","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1373\/clinchem.2004.038323","article-title":"Liquid chromatography\u2013tandem mass spectrometry quantification of globotriaosylceramide in plasma for long-term monitoring of Fabry patients treated with enzyme replacement therapy","volume":"51","author":"TP Roddy","year":"2005","journal-title":"Clinical Chemistry"},{"key":"pone.0277767.ref034","unstructured":"The National Patient Register. https:\/\/econ.au.dk\/the-national-centre-for-register-based-research\/danish-registers\/the-national-patient-register\/browse. Accessed November 20, 2021."},{"issue":"10","key":"pone.0277767.ref035","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1136\/jmedgenet-2020-107162","article-title":"Globotriaosylsphingosine (lyso-Gb3) and analogues in plasma and urine of patients with Fabry disease and correlations with long-term treatment and genotypes in a nationwide female Danish cohort","volume":"58","author":"G Effraimidis","year":"2020","journal-title":"Journal of Medical Genetics"},{"issue":"9","key":"pone.0277767.ref036","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1093\/ndt\/gfy357","article-title":"Age-related renal function decline in Fabry disease patients on enzyme replacement therapy: a longitudinal cohort study","volume":"34","author":"CV Madsen","year":"2018","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"3","key":"pone.0277767.ref037","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/ndt\/gft452","article-title":"Long-term enzyme replacement therapy is associated with reduced proteinuria and preserved proximal tubular function in women with Fabry disease","volume":"29","author":"T Prabakaran","year":"2013","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"6","key":"pone.0277767.ref038","doi-asserted-by":"crossref","first-page":"e39975","DOI":"10.1371\/journal.pone.0039975","article-title":"Mannose 6-phosphate receptor and sortilin mediated endocytosis of \u03b1-galactosidase A in kidney endothelial cells","volume":"7","author":"T Prabakaran","year":"2012","journal-title":"PLoS ONE"},{"issue":"9","key":"pone.0277767.ref039","doi-asserted-by":"crossref","first-page":"e25065","DOI":"10.1371\/journal.pone.0025065","article-title":"Receptor-mediated endocytosis of \u03b1-galactosidase A in human podocytes in Fabry disease","volume":"6","author":"T Prabakaran","year":"2011","journal-title":"PLoS ONE"},{"issue":"4","key":"pone.0277767.ref040","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/14017431.2017.1332383","article-title":"Echocardiographic and clinical findings in patients with Fabry disease during long-term enzyme replacement therapy: a nationwide Danish cohort study","volume":"51","author":"CV Madsen","year":"2017","journal-title":"Scandinavian Cardiovascular Journal"},{"issue":"6","key":"pone.0277767.ref041","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/eurjhf\/hfq073","article-title":"Fabry disease mimicking hypertrophic cardiomyopathy: genetic screening needed for establishing the diagnosis in women","volume":"12","author":"O Havndrup","year":"2010","journal-title":"European Journal of Heart Failure"},{"issue":"12","key":"pone.0277767.ref042","doi-asserted-by":"crossref","first-page":"e0143940","DOI":"10.1371\/journal.pone.0143940","article-title":"Positron emission tomography and magnetic resonance imaging of the brain in Fabry disease: a nationwide, long-time, prospective follow-up","volume":"10","author":"K Korsholm","year":"2015","journal-title":"PLOS ONE"},{"issue":"12","key":"pone.0277767.ref043","doi-asserted-by":"crossref","first-page":"e0225071","DOI":"10.1371\/journal.pone.0225071","article-title":"Significant hearing loss in Fabry disease: Study of the Danish nationwide cohort prior to treatment","volume":"14","author":"PD Yazdanfard","year":"2019","journal-title":"PLOS ONE"},{"issue":"2","key":"pone.0277767.ref044","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1016\/j.ymgme.2020.12.280","article-title":"Hearing loss in Fabry disease: A 16 year follow-up study of the Danish nationwide cohort","volume":"132","author":"PDW Yazdanfard","year":"2021","journal-title":"Molecular Genetics and Metabolism"},{"issue":"3","key":"pone.0277767.ref045","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/aos.12588","article-title":"Ophthalmic experience over 10 years in an observational nationwide Danish cohort of Fabry patients with access to enzyme replacement","volume":"93","author":"HC Fledelius","year":"2014","journal-title":"Acta Ophthalmologica"},{"issue":"1","key":"pone.0277767.ref046","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.pain.2009.06.032","article-title":"Functional and structural nerve fiber findings in heterozygote patients with Fabry disease","volume":"145","author":"A Torvin M\u00f8ller","year":"2009","journal-title":"Pain"},{"issue":"2","key":"pone.0277767.ref047","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1085-9489.2006.00076.x","article-title":"Small-fibre neuropathy in female Fabry patients: reduced allodynia and skin blood flow after topical capsaicin","volume":"11","author":"AT Moller","year":"2006","journal-title":"Journal of the Peripheral Nervous System"},{"issue":"3","key":"pone.0277767.ref048","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1529-8027.2009.00227.x","article-title":"Autonomic skin responses in females with Fabry disease","volume":"14","author":"AT M\u00f8ller","year":"2009","journal-title":"Journal of the Peripheral Nervous System"},{"issue":"5","key":"pone.0277767.ref049","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1399-0004.2012.01947.x","article-title":"Fabry disease in children: agalsidase-beta enzyme replacement therapy","volume":"83","author":"L Borgwardt","year":"2012","journal-title":"Clinical Genetics"},{"key":"pone.0277767.ref050","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/8904_2018_129","article-title":"Enzyme replacement therapy during pregnancy in Fabry patients: Review of published cases of live births and a new case of a severely affected female with Fabry Disease and pre-eclampsia complicating pregnancy","volume":"44","author":"CV Madsen","year":"2019","journal-title":"JIMD Rep"},{"key":"pone.0277767.ref051","doi-asserted-by":"crossref","first-page":"100786","DOI":"10.1016\/j.ymgmr.2021.100786","article-title":"Long-term follow-up of renal function in patients treated with migalastat for Fabry disease","volume":"28","author":"DG Bichet","year":"2021","journal-title":"Molecular Genetics and Metabolism Reports"},{"issue":"6","key":"pone.0277767.ref052","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/ajmg.a.61105","article-title":"Safety of switching to Migalastat from enzyme replacement therapy in Fabry disease: Experience from the Phase 3 ATTRACT study","volume":"179","author":"DA Hughes","year":"2019","journal-title":"American Journal of Medical Genetics Part A"},{"issue":"1","key":"pone.0277767.ref053","article-title":"Migalastat improves diarrhea in patients with Fabry disease: clinical-biomarker correlations from the phase 3","volume":"13","author":"R Schiffmann","year":"2018","journal-title":"FACETS trial. Orphanet Journal of Rare Diseases"},{"issue":"2","key":"pone.0277767.ref054","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/j.ymgme.2018.12.120","article-title":"Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 30-month results from the randomized phase 3 ATTRACT study","volume":"126","author":"U Feldt-Rasmussen","year":"2019","journal-title":"Molecular Genetics and Metabolism"},{"issue":"6","key":"pone.0277767.ref055","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJMoa1510198","article-title":"Treatment of Fabry\u2019s Disease with the pharmacologic Chaperone Migalastat","volume":"375","author":"DP Germain","year":"2016","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"pone.0277767.ref056","doi-asserted-by":"crossref","first-page":"e1666","DOI":"10.1002\/mgg3.1666","article-title":"The benefits and challenges of family genetic testing in rare genetic diseases-lessons from Fabry disease","volume":"9","author":"DP Germain","year":"2021","journal-title":"Mol Genet Genomic Med"},{"issue":"4","key":"pone.0277767.ref057","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1136\/jmedgenet-2017-105080","article-title":"Fabry Disease: prevalence of affected males and heterozygotes with pathogenic GLA mutations identified by screening renal, cardiac and stroke clinics, 1995\u20132017","volume":"55","author":"D Doheny","year":"2018","journal-title":"J Med Genet"},{"issue":"2","key":"pone.0277767.ref058","doi-asserted-by":"crossref","first-page":"200.e1","DOI":"10.1016\/j.amjmed.2017.09.010","article-title":"Identification of Fabry Disease in a Tertiary Referral Cohort of Patients with Hypertrophic Cardiomyopathy","volume":"131","author":"MS Maron","year":"2018","journal-title":"Am J Med"},{"key":"pone.0277767.ref059","unstructured":"The Human Gene Mutation Database www.hgmd.cf.ac.uk\/ac\/index.php Accessed November 20, 2021."},{"issue":"5","key":"pone.0277767.ref060","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"S Richards","year":"2015","journal-title":"Genetics in Medicine"},{"issue":"4","key":"pone.0277767.ref061","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ymgme.2018.02.014","article-title":"Fabry disease revisited: Management and treatment recommendations for adult patients","volume":"123","author":"A Ortiz","year":"2018","journal-title":"Molecular Genetics and Metabolism"},{"issue":"14","key":"pone.0277767.ref062","doi-asserted-by":"crossref","first-page":"7663","DOI":"10.3390\/ijms22147663","article-title":"X Chromosome Inactivation in carriers of Fabry disease: Review and Meta-Analysis","volume":"22","author":"E Viggiano","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"11","key":"pone.0277767.ref063","first-page":"e19358","article-title":"Prevalence of Fabry disease in patients with cryptogenic strokes: a systematic review","volume":"13","author":"JF Ortiz","year":"2021","journal-title":"Cureus"},{"issue":"12","key":"pone.0277767.ref064","doi-asserted-by":"crossref","first-page":"e0260601","DOI":"10.1371\/journal.pone.0260601","article-title":"Nationwide screening for Fabry disease in unselected stroke patients","volume":"16","author":"A Tomek","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"pone.0277767.ref065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jmedgenet-2013-101857","article-title":"A systematic review on screening for Fabry disease: prevalence of individuals with genetic variants of unknown significance","volume":"51","author":"L van der Tol","year":"2014","journal-title":"J Med Genet"},{"issue":"5","key":"pone.0277767.ref066","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/jmedgenet-2014-102797","article-title":"Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease","volume":"52","author":"DP Germain","year":"2015","journal-title":"J Med Genet"},{"issue":"3","key":"pone.0277767.ref067","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ymgme.2018.09.007","article-title":"The effect of enzyme replacement therapy on clinical outcomes in female patients with Fabry disease\u2013A systematic literature review by a European panel of experts","volume":"126","author":"DP Germain","year":"2019","journal-title":"Molecular Genetics and Metabolism"},{"issue":"7","key":"pone.0277767.ref068","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1136\/jmedgenet-2015-103486","article-title":"Time to treatment benefit for adult patients with Fabry disease receiving agalsidase \u03b2: data from the Fabry Registry","volume":"53","author":"A Ortiz","year":"2016","journal-title":"J Med Genet"},{"issue":"3","key":"pone.0277767.ref069","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ymgme.2018.06.004","article-title":"European expert consensus statement on therapeutic goals in Fabry disease","volume":"124","author":"C Wanner","year":"2018","journal-title":"Molecular Genetics and Metabolism"},{"issue":"3","key":"pone.0277767.ref070","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1093\/ndt\/gfr420","article-title":"Renal outcomes of agalsidase beta treatment for Fabry disease: role of proteinuria and timing of treatment initiation","volume":"27","author":"DG Warnock","year":"2012","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"9","key":"pone.0277767.ref071","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/01.gim.0000237866.70357.c6","article-title":"Fabry disease: guidelines for the evaluation and management of multi-organ system involvement","volume":"8","author":"CM Eng","year":"2006","journal-title":"Genet Med"},{"issue":"2","key":"pone.0277767.ref072","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ymgme.2007.09.013","article-title":"Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry","volume":"93","author":"WR Wilcox","year":"2008","journal-title":"Mol Genet Metab"},{"issue":"1","key":"pone.0277767.ref073","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10677-020-10133-9","article-title":"The Right Not to Know: some Steps towards a Compromise","volume":"24","author":"B Davies","year":"2021","journal-title":"Ethic Theory Moral Prac"},{"key":"pone.0277767.ref074","unstructured":"OECD, Policies EO on HS and. Denmark: Country Health Profile 2021 [Internet]. 2021. https:\/\/www.oecd-ilibrary.org\/content\/publication\/2dce8636-en"},{"issue":"11","key":"pone.0277767.ref075","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1097\/GIM.0b013e3181bb05bb","article-title":"Life expectancy and cause of death in males and females with Fabry disease: Findings from the Fabry Registry","volume":"11","author":"S Waldek","year":"2009","journal-title":"Genetics in Medicine"},{"issue":"2","key":"pone.0277767.ref076","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s10545-007-0521-2","article-title":"Fabry disease: baseline medical characteristics of a cohort of 1765 males and females in the Fabry Registry","volume":"30","author":"CM Eng","year":"2007","journal-title":"J Inherit Metab Dis"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0287268","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000}}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0277767","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T18:28:52Z","timestamp":1668623332000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0277767"}},"subtitle":[],"editor":[{"given":"Alessio","family":"Branchini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,11,16]]},"references-count":76,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0277767","relation":{"correction":[{"id-type":"doi","id":"10.1371\/journal.pone.0287268","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,16]]}}}